Correction to: Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines

Teng, Wei; Chang, Ting‑Tsung; Yang, Hwai‑I; Peng, Cheng‑Yuan; Su, Chien‑Wei; Su, Tung‑Hung; Hu, Tsung‑Hui; Yu, Ming‑Lung; Yang, Hung‑Chih; Wu, Jaw‑Ching

doi:10.1007/s12072-023-10634-6

Correction to: Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines

Correction
Published: 22 January 2024

(2024)
Cite this article

Download PDF

Hepatology International Aims and scope Submit manuscript

Correction to: Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines

Download PDF

Wei Teng^1,2,
Ting‑Tsung Chang³,
Hwai‑I Yang⁴,
Cheng‑Yuan Peng⁵,
Chien‑Wei Su⁶,
Tung‑Hung Su⁷,
Tsung‑Hui Hu⁸,
Ming‑Lung Yu⁹,
Hung‑Chih Yang⁷ &
…
Jaw‑Ching Wu^1,10,11

381 Accesses
Explore all metrics

The Original Article was published on 06 November 2021

Correction to: Hepatology International (2021) 15:1421–1430 https://doi.org/10.1007/s12072-021-10263-x

Authors would like to add below funding information to their publication.

This study was supported by funding from Ministry of Science and Technology (National Science and Technology Council) (104-2314-B-182A-048-MY3; 110-2314-B-A49A-505; 110-2314-B-075-010-MY3), VGHUST Joint Research Program, Tsou Foundation (VGHUST110-G7-3-3), VGHTPE Research Program (V107C-161, V108C-059 and V109C-049), Ministry of Health and Welfare (MOHW107-TDU-B-211-114019; 108-TDU-B-211-124019; 109-TDU-B-211-134019; 110-TDU-B-211-144019) and Cancer Progression Research Center, National Yang-Ming University from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education.

The original article has been corrected.

Author information

Authors and Affiliations

Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, Republic of China
Wei Teng & Jaw‑Ching Wu
Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan, Republic of China
Wei Teng
Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan, Republic of China
Ting‑Tsung Chang
Genomics Research Center, Academia Sinica, Taipei, Taiwan, Republic of China
Hwai‑I Yang
Center for Digestive Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan, Republic of China
Cheng‑Yuan Peng
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, Republic of China
Chien‑Wei Su
Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan, Republic of China
Tung‑Hung Su & Hung‑Chih Yang
Department of Gastroenterology and Hepatology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan, Republic of China
Tsung‑Hui Hu
Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, Republic of China
Ming‑Lung Yu
Translational Research Division, Medical Research Department, Taipei Veterans General Hospital, Taipei, Taiwan, Republic of China
Jaw‑Ching Wu
Cancer Progression Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan, Republic of China
Jaw‑Ching Wu

Authors

Wei Teng
View author publications
You can also search for this author in PubMed Google Scholar
Ting‑Tsung Chang
View author publications
You can also search for this author in PubMed Google Scholar
Hwai‑I Yang
View author publications
You can also search for this author in PubMed Google Scholar
Cheng‑Yuan Peng
View author publications
You can also search for this author in PubMed Google Scholar
Chien‑Wei Su
View author publications
You can also search for this author in PubMed Google Scholar
Tung‑Hung Su
View author publications
You can also search for this author in PubMed Google Scholar
Tsung‑Hui Hu
View author publications
You can also search for this author in PubMed Google Scholar
Ming‑Lung Yu
View author publications
You can also search for this author in PubMed Google Scholar
Hung‑Chih Yang
View author publications
You can also search for this author in PubMed Google Scholar
Jaw‑Ching Wu
View author publications
You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jaw‑Ching Wu.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Teng, W., Chang, T., Yang, H. et al. Correction to: Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines. Hepatol Int (2024). https://doi.org/10.1007/s12072-023-10634-6

Download citation

Published: 22 January 2024
DOI: https://doi.org/10.1007/s12072-023-10634-6

Use our pre-submission checklist

Avoid common mistakes on your manuscript.

Correction to: Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines

Author information

Authors and Affiliations

Corresponding author

Additional information

Publisher's Note

Rights and permissions

About this article

Cite this article

Share this article

Search

Navigation